AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12471401
Drug: Injected measles
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injected measles vaccine (Edmonston-Zagreb)
Trial: 12471401
Drug: Injected measles-rubella
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injected measles-rubella vaccine (Edmonston-Zagreb with RA27/3)
Trial: 12471401
Drug: Injected Schwarz
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injected Schwarz measles vaccine
Trial: 12471401
Drug: Aerosolized measles
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized measles vaccine (1000 plaque-forming units of Edmonston-Zagreb)
Trial: 329085
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 to 120 mg per day)
Trial: 29496473
Drug: Etonogestrel implant
RxNorm normalized name: Etonogestrel Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etonogestrel implant
Trial: 22263337
Drug: Desensitizer gel
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desensitizer gel (DG; 5% potassium nitrate and 2% sodium fluoride) applied for 10 minutes before bleaching treatment with 16% carbamide peroxide (CP)
Trial: 22263337
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel applied for 10 minutes before bleaching treatment with 16% carbamide peroxide (CP)
Trial: 16384850
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human TSH (rhTSH) preparation with 3.7 GBq (100 mCi) 131I in euthyroid patients
Trial: 16384850
Drug: Radiation dose
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiation dose to blood in euthyroid group
Trial: 15015442
Drug: Kebimin decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kebimin decoction (KD), given one dose per day for 10 days, with 1-3 courses given successively.
Trial: 15015442
Drug: Xinfang Rhinitis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xinfang Rhinitis capsule, treated for 30 days.
Trial: 15015442
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Xinfang Rhinitis capsule)
Trial: 11038993
Drug: Tong Xin
RxNorm normalized name: beef tongue preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tong Xin Luo (TXL) capsule
Trial: 9925903
Drug: Control (sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (sterile water administered three times)
Trial: 9925903
Drug: Repeated doses
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated doses of sucrose (0.05 ml of 24% sucrose solution administered three times)
Trial: 6988173
Drug: Oral terbutaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbutaline at 2.5 to 5 mg 3-times daily
Trial: 28251804
Drug: Daily micronutrient-rich
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily micronutrient-rich snack containing green leafy vegetables, fruit, and milk
Trial: 28251804
Drug: Daily micronutrient-rich
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily micronutrient-rich snack
Trial: 26394649
Drug: Caffeine anhydrous
RxNorm normalized name: Caffeine anhydrous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine anhydrous (CAF) 300 mg flat dose (3-5 mg/kg bodyweight)
Trial: 26394649
Drug: Coffee (COF)
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coffee (COF) 8.9 g (303 mg caffeine)
Trial: 26394649
Drug: Placebo (PLA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PLA) 3.8 g non-caloric flavouring
Trial: 23676636
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg every 6 months for 1 year (TP1)
Trial: 23676636
Drug: Higher concerns
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher concerns about medication scores
Trial: 20035910
Drug: Eszopiclone 3
RxNorm normalized name: eszopiclone 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eszopiclone 3 mg orally
Trial: 27044596
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg caffeine
Trial: 10333820
Drug: Loperamide-simethicone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide-simethicone (2 mg loperamide and 125 mg simethicone)
Trial: 10333820
Drug: Loperamide alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide alone (2 mg)
Trial: 6358654
Drug: Conventional immunosuppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional immunosuppression (low-dose steroids)
Trial: 18797469
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with uracil-tegafur (UFT)
Trial: 15833522
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of 7.5 mg intranasal PT-141 and 25 mg sildenafil
Trial: 15833522
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg sildenafil and intranasal placebo spray
Trial: 15833522
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet and intranasal placebo spray
Trial: 8748428
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 1 mg of alprazolam and 200 mg of nefazodone twice daily
Trial: 22003053
Drug: Rosuvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (20 mg single dose)
Trial: 22003053
Drug: Rosuvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (20 mg/day for 21 days) and Celecoxib (100 mg bid)
Trial: 17877886
Drug: Episodic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Episodic therapy with antiviral medications (1-, 2-, and 3-day courses compared to standard 5-day regimens)
Trial: 17877886
Drug: Suppressive antiviral
RxNorm normalized name: Buckley's Cough Suppressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suppressive antiviral therapy
Trial: 17877886
Drug: Antiherpes therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiherpes therapy in HIV-positive patients
Trial: 9772413
Drug: Captopril (6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (6.25 mg initial dose, 12.5 mg 2 hours later, and then 12.5 mg three times daily for 4 weeks)
Trial: 3698180
Drug: High-dose IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IV dexamethasone
Trial: 3698180
Drug: High-dose IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IV metoclopramide (LD-CDDP group)
Trial: 3698180
Drug: High-dose IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IV metoclopramide (LD-CDDP combination chemotherapy)
Trial: 3698180
Drug: High-dose IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IV metoclopramide (previously untreated patients)
Trial: 31450983
Drug: Luseogliflozin-sitagliptin (LS);
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luseogliflozin-sitagliptin (LS); luseogliflozin 2.5 mg for 0-12 weeks, then luseogliflozin plus sitagliptin 50 mg for 12-24 weeks
Trial: 31450983
Drug: Sitagliptin-luseogliflozin (SL);
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin-luseogliflozin (SL); sitagliptin 50 mg for 0-12 weeks, then sitagliptin plus luseogliflozin 2.5 mg for 12-24 weeks
Trial: 23098678
Drug: Tramadol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (200 mg and 400 mg)
Trial: 21725510
Drug: Intravenous ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ibandronate (1 mg/3-monthly)
Trial: 21725510
Drug: Intermittent sustained-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent sustained-release sodium-fluoride (50 mg) with colecalciferol (1000 IU) and calcium-citrate (800 mg)
Trial: 19515090
Drug: Computer-assisted dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted dosing
Trial: 19515090
Drug: Manual dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual dosing
Trial: 10193286
Drug: Tramadol 3
RxNorm normalized name: TRAMADOL 300MG (RYZOLT) SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 3 mg kg-1
Trial: 8092425
Drug: sublingual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual therapy with a solution of purified, standardized allergen preparation (Stallergènes)
Trial: 11139095
Drug: Other drugs
RxNorm normalized name: Other drugs for bile therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other drugs
Trial: 28477228
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (300 µg) with intravenous patient-controlled analgesia (IV-PCA)
Trial: 28477228
Drug: Intravenous patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled analgesia (IV-PCA) only
Trial: 15114430
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate aqueous nasal spray (MFANS) 50 microg/spray, 8 sprays per nostril every 8 h for 4 days
Trial: 15114430
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray (FPANS) 50 microg/spray, 8 sprays per nostril every 8 h for 4 days
Trial: 15114430
Drug: Placebo aqueous
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo aqueous nasal spray (placebo ANS)
Trial: 9438604
Drug: Radiotherapy (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy (40 Gy with 5-fluorouracil as a sensitising agent)
Trial: 9438604
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months chemotherapy (5-fluorouracil and folinic acid)
Trial: 3120758
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of radiotherapy and chemotherapy
Trial: 29751849
Drug: Continuous compression
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous compression stimulation (5-minute massage therapy)
Trial: 29751849
Drug: Sham massage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham massage therapy (touch without compression)
Trial: 10975752
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (10 mg/kg/day) for 12 months after interferon therapy
Trial: 10975752
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for 12 months after interferon therapy
Trial: 9273082
Drug: Diagnostic examinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diagnostic examinations (biopsy) and curative treatments (surgery or radiotherapy)
Trial: 8287314
Drug: i.v. infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. infusion of pamidronate disodium 15 mg
Trial: 2953116
Drug: Celiprolol (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol (3 X 100 micrograms oral)
Trial: 29433963
Drug: Trastuzumab and
RxNorm normalized name: pertuzumab and trastuzumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab and pertuzumab plus metronomic oral cyclophosphamide
Trial: 18398153
Drug: Bexarotene 400
RxNorm normalized name: Bexarotene
DrugBank: Bexarotene (DB00307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Bexarotene 400 mg/m(2)/d combined with carboplatin and paclitaxel
Trial: 16840727
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg once-daily lenalidomide
Trial: 10599356
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg/day)
Trial: 3531295
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg twice daily
Trial: 31886682
Drug: Early substance
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early substance involvement (heavy drinking, marijuana use, daily smoking, and other illicit drug use)
Trial: 16997112
Drug: Mandibular block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular block using 2.1 mL of 2% lidocaine with 1:100 000 epinephrine for the inferior alveolar nerve, lingual nerve, and/or buccal nerve.
Trial: 15196600
Drug: Lithium augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium augmentation of nortriptyline
Trial: 12544380
Drug: Placebo augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo augmentation of nortriptyline
Trial: 10967487
Drug: Benzyl benzoate
RxNorm normalized name: Benzyl Benzoate
DrugBank: Benzyl benzoate (DB00676)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzyl benzoate preparation (same concentration as Lippia oil)
Trial: 9100588
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose L (0.2 mg/kg)
Trial: 9100588
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose L (0.75 mg/kg)
Trial: 9100588
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose L (0.2 mg/kg) in fasted nonobese
Trial: 8308943
Drug: Cocaine abstinence
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine abstinence treatment
Trial: 25173541
Drug: Apixaban 5mg
RxNorm normalized name: APIXABAN 5MG TAB
DrugBank: Apixaban (DB06605)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Apixaban 5mg twice daily
Trial: 16826390
Drug: Deep sedation
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep sedation (continuous infusion of midazolam and fentanyl) without neuromuscular blockade
Trial: 10915751
Drug: Famciclovir 500
RxNorm normalized name: famciclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 500 mg 3 times daily
Trial: 12958617
Drug: Cerivastatin discontinuation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin discontinuation
Trial: 10991852
Drug: Fosfomycin 4
RxNorm normalized name: FOSFOMYCIN
DrugBank: Fosfomycin (DB00828)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin 4 g
Trial: 10991852
Drug: Fosfomycin 8
RxNorm normalized name: FOSFOMYCIN
DrugBank: Fosfomycin (DB00828)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin 8 g
Trial: 8435695
Drug: Home based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home based care (daily living programme)
Trial: 27108819
Drug: Benzydamine hydrochloride
RxNorm normalized name: benzydamine hydrochloride
DrugBank: Benzydamine (DB09084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzydamine hydrochloride gel
Trial: 27108819
Drug: 5% lidocaine
RxNorm normalized name: LIDOCAINE 5 g in 100 g TOPICAL CREAM [Healcome Tattoo Numbing Cream 5% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% lidocaine hydrochloride gel
Trial: 19640357
Drug: Nelfabiovir (Bakhtar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfabiovir (Bakhtar Bioshimi, Iran) 250 mg
Trial: 15190828
Drug: nCPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nCPAP treatment from 22:00 to 6:00 per night for 1 month
Trial: 9821925
Drug: Ototopical antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ototopical antibiotics plus topical phenylephrine
Trial: 9821925
Drug: Ototopical antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ototopical antibiotics
Trial: 9221158
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg of moradole
Trial: 6796322
Drug: Propranolol 20
RxNorm normalized name: propranolol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 20 mg orally four times daily for 5 days
Trial: 25823275
Drug: Placebo four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo four times daily for 5 days
Trial: 23484369
Drug: Polaprezinc (zinc
RxNorm normalized name: polaprezinc (zinc carnosine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polaprezinc (zinc agent)
Trial: 22159931
Drug: Gabapentin 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 1,200 mg day-1
Trial: 22159931
Drug: Pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300 mg day-1
Trial: 17956454
Drug: HOMA‐IR and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOMA‐IR and fasting insulin
Trial: 11340827
Drug: Preschool speech
RxNorm normalized name: TRACH TUBE,SPEECH SZ 10 BLOM #313-30-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preschool speech and language therapy services
Trial: 7920892
Drug: Testosterone or
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone or GnRH treatment
Trial: 23174047
Drug: clindamycin 1%/BPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clindamycin 1%/BPO 5% gel
Trial: 23174047
Drug: adapalene 0.1%/BPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: adapalene 0.1%/BPO 2.5% gel
Trial: 20158589
Drug: Tacrolimus 0.03%
RxNorm normalized name: TACROLIMUS 0.03% OINT,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus 0.03% ointment, applied twice weekly for 12 months
Trial: 18544020
Drug: tgAAC09 boost
RxNorm normalized name: TGAAC09
DrugBank: TGAAC09 (DB06363)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tgAAC09 boost dose of 3 x 10(11) DRP
Trial: 7537110
Drug: Interleukin-6 (IL-6)
RxNorm normalized name: autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6) (also termed ssCART-19 cells)
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-6 (IL-6) administered at escalating doses from 0.5 to 10 micrograms/kg/d during chemotherapy cycles 2 to 6.
Trial: 7537110
Drug: Interleukin-6 (IL-6)
RxNorm normalized name: autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6) (also termed ssCART-19 cells)
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-6 (IL-6) administered after chemotherapy.
Trial: 7537110
Drug: Interleukin-6 (IL-6)
RxNorm normalized name: autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6) (also termed ssCART-19 cells)
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-6 (IL-6) administered at escalating doses up to 10 micrograms/kg/d.
Trial: 7049582
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (hydrochlorothiazide plus triamterene, with the addition of methyldopa if necessary)
Trial: 19127161
Drug: Injection therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection therapy (corticosteroids, local anesthetics, and other drugs)
Trial: 9702843
Drug: Itraconazole capsules
RxNorm normalized name: Itraconazole Capsules
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole capsules (200 mg once daily for 28 days)
Trial: 9702843
Drug: Itraconazole capsules
RxNorm normalized name: Itraconazole Capsules
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole capsules (200 mg twice daily for 28 days)
Trial: 9702843
Drug: Intravenous itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous itraconazole followed by itraconazole capsules twice daily
Trial: 29189517
Drug: Oxycodone/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone/naloxone
Trial: 16564254
Drug: L-arginine (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (7.5 g in 500 mL of cardioplegic solution)
Trial: 14602763
Drug: TRIAC (19.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRIAC (19.6 micro g/kg)
Trial: 14602763
Drug: L-T4 (1.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-T4 (1.7 microg/kg)
Trial: 20447070
Drug: L-T4
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-T4
Trial: 8775350
Drug: Lifestyle education
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle education (LSE) - Weekly lifestyle discussions
Trial: 6463068
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg oxiconazole (one vaginal tablet)
Trial: 6463068
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg oxiconazole